163 related articles for article (PubMed ID: 32435154)
1. HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation.
Guo F; Li J; Qi Y; Hou J; Chen H; Jiang SW
Cancer Cell Int; 2020; 20():163. PubMed ID: 32435154
[TBL] [Abstract][Full Text] [Related]
2. Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines.
Lu Q; Chen H; Senkowski C; Wang J; Wang X; Brower S; Glasgow W; Byck D; Jiang SW; Li J
Oncol Rep; 2016 Jan; 35(1):163-70. PubMed ID: 26497244
[TBL] [Abstract][Full Text] [Related]
3. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
4. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.
Lee S; Choi S; Lee Y; Chung D; Hong S; Park N
J Obstet Gynaecol Res; 2017 Jan; 43(1):220-227. PubMed ID: 27862665
[TBL] [Abstract][Full Text] [Related]
5. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.
Wang H; Zhu L; Gao J; Hu Z; Lin B
Oncol Rep; 2015 Jan; 33(1):403-12. PubMed ID: 25354091
[TBL] [Abstract][Full Text] [Related]
6. Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways.
Kong X; Chang X; Cheng H; Ma R; Ye X; Cui H
Int J Gynecol Cancer; 2014 Mar; 24(3):427-36. PubMed ID: 24557433
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer.
Zhu L; Zhuang H; Wang H; Tan M; Schwab CL; Deng L; Gao J; Hao Y; Li X; Gao S; Liu J; Lin B
Oncotarget; 2016 Jan; 7(1):729-44. PubMed ID: 26575020
[TBL] [Abstract][Full Text] [Related]
8. Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers.
Li J; Chen H; Curcuru JR; Patel S; Johns TO; Patel D; Qian H; Jiang SW
Curr Drug Targets; 2017; 18(10):1158-1164. PubMed ID: 28382859
[TBL] [Abstract][Full Text] [Related]
9. Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.
Liu Q; Liu DW; Zheng MJ; Deng L; Wang HM; Jin S; Liu JJ; Hao YY; Zhu LC; Lin B
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955501
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells.
Zhu L; Guo Q; Jin S; Feng H; Zhuang H; Liu C; Tan M; Liu J; Li X; Lin B
Oncol Rep; 2016 Sep; 36(3):1592-604. PubMed ID: 27430660
[TBL] [Abstract][Full Text] [Related]
11. miR-19b-3p promotes human pancreatic cancer Capan-2 cells proliferation by targeting phosphatase and tension homolog.
Song M; Sun M; Xia L; Chen W; Yang C
Ann Transl Med; 2019 Jun; 7(11):236. PubMed ID: 31317006
[TBL] [Abstract][Full Text] [Related]
12. HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines.
Li J; Chen H; Mariani A; Chen D; Klatt E; Podratz K; Drapkin R; Broaddus R; Dowdy S; Jiang SW
Int J Mol Sci; 2013 Mar; 14(3):6026-43. PubMed ID: 23502467
[TBL] [Abstract][Full Text] [Related]
13. The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells.
Zhong Y; Xia Z; Liu J; Lin Y; Zan H
Oncol Rep; 2012 Apr; 27(4):1003-10. PubMed ID: 22200969
[TBL] [Abstract][Full Text] [Related]
14. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.
Huang T; Jiang SW; Qin L; Senkowski C; Lyle C; Terry K; Brower S; Chen H; Glasgow W; Wei Y; Li J
Int J Mol Sci; 2015 Jan; 16(2):2956-70. PubMed ID: 25642754
[TBL] [Abstract][Full Text] [Related]
15. Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.
Zheng C; Jia W; Tang Y; Zhao H; Jiang Y; Sun S
J Exp Clin Cancer Res; 2012 Oct; 31(1):84. PubMed ID: 23034174
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the short-term efficacy and serum markers between lobaplatin/paclitaxel- And carboplatin/paclitaxel-based adjuvant chemotherapy in patient with ovarian cancer.
Wang W; Liu M; Ding B
J Clin Pharm Ther; 2021 Feb; 46(1):166-172. PubMed ID: 33098169
[TBL] [Abstract][Full Text] [Related]
17. High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Kubota Y; Hamada K; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Kobayashi S; Tsunoda T; Wada S
Int J Oncol; 2021 Jan; 58(1):57-69. PubMed ID: 33367933
[TBL] [Abstract][Full Text] [Related]
18. The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.
Gao L; Cheng HY; Dong L; Ye X; Liu YN; Chang XH; Cheng YX; Chen J; Ma RQ; Cui H
J Int Med Res; 2011; 39(5):1645-60. PubMed ID: 22117965
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis.
Plath T; Peters M; Detjen K; Welzel M; von Marschall Z; Radke C; Wiedenmann B; Rosewicz S
J Natl Cancer Inst; 2002 Jan; 94(2):129-42. PubMed ID: 11792751
[TBL] [Abstract][Full Text] [Related]
20. [Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].
Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):739-45. PubMed ID: 27371838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
